ACE Acetabular Cup UK Multi-centre PMCF Study
A Prospective UK Multi-Centre Post Market Clinical Follow-up Study of the JRI Orthopaedic ACE Acetabular Cup System
JRI Orthopaedics
225 participants
Jun 6, 2023
OBSERVATIONAL
Conditions
Summary
A total hip replacement is one of the most successful and cost-effective surgical procedures in orthopaedics, and involves replacing both the hip ball and socket. Its goal is to provide pain relief, allowing the person to return to a normal lifestyle. JRI Orthopaedics have developed the ACE Acetabular Cup System, which has a H-A.C. coating to promote ossoeintegration of the device within the host bone. To increase the surgeons choice and thus suitability for the patient, there is the option of 3 different socket liners (ceramic, polymer or dual mobility). To ensure maximum safety and performance of medical devices surveillance of the device should be carried out over the devices lifetime. This study is a 10 year surveillance study to assess the clinical, functional and radiological outcomes of the CE-marked ACE Acetabular Cup System. This is done by examining patient outcomes through questionnaires, reviews of X-rays and complications by patients who have received a total hip replacement using the ACE Acetabular Cup System at participating sites.
Eligibility
Inclusion Criteria2
- Patients deemed suitable for elective primary THR, as per indications in the IFU.
- Male or female, 18 years or older.
Exclusion Criteria5
- Patients who are unable to provide written informed consent.
- Patients deemed unsuitable for THR, as per contra-indications in the IFU.
- Patients indicated for THR as a result of trauma (i.e. neck of femur fracture).
- Patients receiving implants other than the approved combination, i.e. an ACE Acetabular Cup System with a JRI femoral stem and head.
- Patients who are unable to comply with the protocol.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Primary elective total hip replacement
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04123431